Leslie L. Iversen, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 60,000 shares at $25.03 ($1.5M) on 2014-01-02, disclosed to the SEC on 2014-01-03.
Scheduled sale ($1.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACAD | SELL | 2013-09-13 | $1.4M | — | Filing → |
| ACAD | BUY | 2009-05-20 | $5K | — | Filing → |